by Stacey Johnson | Sep 30, 2022
After returning from CellCAN’s 2022 Strategic Forum in Ottawa, Ontario, where Canada’s cell and gene therapy biomanufacturing community came together to share information and network, it is clear that the country’s biomanufacturing landscape is improving. As I and...
by Sara M. Nolte | Sep 21, 2022
We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more...
by Cal Strode | Sep 15, 2022
OmniaBio Inc., a subsidiary of CCRM, is building the largest facility of its kind in Canada, providing specialized manufacturing to the flourishing cell and gene therapy (CGT) industry. The new contract development and manufacturing organization (CDMO) will focus on...
by Stacey Johnson | Sep 9, 2022
Now is a fantastic time to be an undergraduate student, graduate student or postdoc (sometimes referred to as trainees or highly qualified personnel) interested in regenerative medicine. In addition to the education you receive in the classroom or lab, your university...
by Francesco Zangari | Sep 1, 2022
This post is a collaborative effort, written by the ComSciConCAN2022 organizing committee: Katie Pullella, Ben Davis-Purcell, Shealin Murray, Shanzeh Mumtaz Ahmed and Francesco Zangari. When the inaugural ComSciConCAN took place in 2019 at McMaster University, it...
Comments